90% of pricing managers unsatisfied with new drug price

By Eo, Yun-Ho | translator Kim, Jung-Ju

23.05.18 16:58:53

가나다라 0

Announced survey results of 56 pricing managers in the industry

Pointed out the need to improve the CDDC...pricing system should be set separately for each indication

Study results showed that about 90% of the drug pricing managers in Korea are not satisfied with the value recognized for new drugs.

Recently, a study on ‘'An Industry Survey on Unmet Needs in South Korea’s New Drug Listing System' was published on the online version of the medical science journal Springer (https://link.springer.com/article/10.1007/s43441-023-00531-3). 6 authors including Professor Jong-Hyuk Lee of the Chung-Ang University College of Pharmacy, expert advisory member Sungju Kim from Lee&Ko participated in the study.

The study was conducted with the cooperation of 3 industry associations: Korea Pharmaceutical and Bio-Pharma Manufacturers Association, the Korean Research

Eo, Yun-Ho(unkindfish@dailypharm.com)

If you want to see the full article, please JOIN US (click)